Who makes Mirtazapine and Dexamethasone?

Mirtazapine and Dexamethasone is developed by Ain Shams University.

What development phase is Mirtazapine and Dexamethasone in?

Mirtazapine and Dexamethasone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Mirtazapine and Dexamethasone

Ain Shams University · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Mirtazapine and Dexamethasone
Sponsor	Ain Shams University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Mirtazapine Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting (EARLY_PHASE1)
Nutrition and Pharmacological Algorithm for Oncology Patients Study (PHASE4)
Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis (PHASE3)
Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering (PHASE4)
Effects of Aprepitant/Dexamethasone Versus Mertazepine /Dexamethasone on Postoperative Nausea and Vomiting (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Mirtazapine and Dexamethasone CI brief — competitive landscape report
Mirtazapine and Dexamethasone updates RSS · CI watch RSS
Ain Shams University portfolio CI